• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用综合生物信息学分析鉴定 ALDH3A2 为胃腺癌的新型预后生物标志物。

Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.

机构信息

Department of Digestive, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Shanghai, 201399, China.

Department of General Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Shanghai, 201399, China.

出版信息

BMC Cancer. 2020 Nov 4;20(1):1062. doi: 10.1186/s12885-020-07493-x.

DOI:10.1186/s12885-020-07493-x
PMID:33148208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7640415/
Abstract

BACKGROUND

Extensive research has revealed that genes play a pivotal role in tumor development and growth. However, the underlying involvement of gene expression in gastric carcinoma (GC) remains to be investigated further.

METHODS

In this study, we identified overlapping differentially expressed genes (DEGs) by comparing tumor tissue with adjacent normal tissue using the Gene Expression Omnibus (GEO) and the Cancer Genome Atlas (TCGA) database.

RESULTS

Our analysis identified 79 up-regulated and ten down-regulated genes. Functional enrichment analysis and prognosis analysis were conducted on the identified genes, and the fatty aldehyde dehydrogenase (FALDH) gene, ALDH3A2, was chosen for more detailed analysis. We performed Gene Set Enrichment Analysis (GSEA) and immunocorrelation analysis (infiltration, copy number alterations, and checkpoints) to elucidate the mechanisms of action of ALDH3A2 in depth. The immunohistochemical (IHC) result based on 140 paraffin-embedded human GC samples indicated that ALDH3A2 was over-expressed in low-grade GC cases and the OS of patients with low expression of ALDH3A2 was significantly shorter than those with high ALDH3A2 expression. In vitro results indicated that the expression of ALDH3A2 was negatively correlated with PDCD1, PDCD1LG2, and CTLA-4.

CONCLUSION

We conclude that ALDH3A2 might be useful as a potential reference value for the relief and immunotherapy of GC, and also as an independent predictive marker for the prognosis of GC.

摘要

背景

大量研究表明,基因在肿瘤的发生和生长中起着关键作用。然而,基因表达在胃癌(GC)中的潜在作用仍有待进一步研究。

方法

本研究通过比较基因表达综合数据库(GEO)和癌症基因组图谱(TCGA)数据库中的肿瘤组织与相邻正常组织,鉴定重叠差异表达基因(DEGs)。

结果

我们的分析确定了 79 个上调和 10 个下调基因。对鉴定出的基因进行功能富集分析和预后分析,选择脂肪酸醛脱氢酶(FALDH)基因 ALDH3A2 进行更详细的分析。我们进行了基因集富集分析(GSEA)和免疫相关性分析(浸润、拷贝数改变和检查点),以深入阐明 ALDH3A2 的作用机制。基于 140 例石蜡包埋人 GC 样本的免疫组化(IHC)结果表明,ALDH3A2 在低级别 GC 病例中过表达,并且 ALDH3A2 低表达的患者的 OS 明显短于 ALDH3A2 高表达的患者。体外结果表明,ALDH3A2 的表达与 PDCD1、PDCD1LG2 和 CTLA-4 呈负相关。

结论

我们得出结论,ALDH3A2 可能是 GC 缓解和免疫治疗的潜在参考值,也是 GC 预后的独立预测标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/a40e0e8272e8/12885_2020_7493_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/80dc39fa0989/12885_2020_7493_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/cc8fdfec1a39/12885_2020_7493_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/2d7283f128ed/12885_2020_7493_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/49e2c884ae0d/12885_2020_7493_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/e3cb1c2a7e23/12885_2020_7493_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/d8de22ff19a9/12885_2020_7493_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/cb82de1edfbe/12885_2020_7493_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/a40e0e8272e8/12885_2020_7493_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/80dc39fa0989/12885_2020_7493_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/cc8fdfec1a39/12885_2020_7493_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/2d7283f128ed/12885_2020_7493_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/49e2c884ae0d/12885_2020_7493_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/e3cb1c2a7e23/12885_2020_7493_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/d8de22ff19a9/12885_2020_7493_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/cb82de1edfbe/12885_2020_7493_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1a3/7640415/a40e0e8272e8/12885_2020_7493_Fig8_HTML.jpg

相似文献

1
Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.利用综合生物信息学分析鉴定 ALDH3A2 为胃腺癌的新型预后生物标志物。
BMC Cancer. 2020 Nov 4;20(1):1062. doi: 10.1186/s12885-020-07493-x.
2
Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.胃癌中 FKBP10 表达的综合评估及其预后潜力。
Oncol Rep. 2019 Aug;42(2):615-628. doi: 10.3892/or.2019.7195. Epub 2019 Jun 11.
3
Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.食管腺癌和巴雷特食管中的生物标志物鉴定和反式调控网络分析。
World J Gastroenterol. 2019 Jan 14;25(2):233-244. doi: 10.3748/wjg.v25.i2.233.
4
Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.整合生物信息学分析揭示胃癌中新型关键生物标志物和潜在候选小分子药物。
Pathol Res Pract. 2019 May;215(5):1038-1048. doi: 10.1016/j.prp.2019.02.012. Epub 2019 Feb 28.
5
Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.ZNF860在胃癌无复发生存中的预后价值及其潜在调控网络的生物信息学分析
Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):162-170. doi: 10.26355/eurrev_201901_16760.
6
Comprehensive Analysis of Ferroptosis-Related Markers for the Clinical and Biological Value in Gastric Cancer.胃癌中与铁死亡相关标志物的临床和生物学价值的综合分析。
Oxid Med Cell Longev. 2021 Oct 27;2021:7007933. doi: 10.1155/2021/7007933. eCollection 2021.
7
Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.基于生物信息学分析鉴定的三 miRNA -signature 预测胃癌患者的预后。
World J Gastroenterol. 2018 Mar 21;24(11):1206-1215. doi: 10.3748/wjg.v24.i11.1206.
8
Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.基于 TCGA 和 GEO 数据集鉴定胃腺癌肿瘤微环境中的预后相关基因。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20200980.
9
Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.长链非编码 RNA 与胃癌发病机制和预后关系的综合分析。
DNA Cell Biol. 2020 Feb;39(2):299-309. doi: 10.1089/dna.2019.5161. Epub 2020 Jan 14.
10
Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.生物信息学分析鉴定凝血因子 II 受体为胃腺癌的潜在生物标志物。
Sci Rep. 2024 Jan 30;14(1):2468. doi: 10.1038/s41598-024-52397-6.

引用本文的文献

1
Impact of Extracellular Matrix-Related Genes on the Tumor Microenvironment and Prognostic Indicators in Esophageal Cancer: A Comprehensive Analytical Study.细胞外基质相关基因对食管癌肿瘤微环境和预后指标的影响:一项全面的分析研究。
Genet Res (Camb). 2024 Jul 25;2024:3577395. doi: 10.1155/2024/3577395. eCollection 2024.
2
ALDH2 is a novel biomarker and exerts an inhibitory effect on melanoma.ALDH2 是一种新型生物标志物,对黑色素瘤具有抑制作用。
Sci Rep. 2024 Feb 20;14(1):4183. doi: 10.1038/s41598-024-54084-y.
3
Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cells.

本文引用的文献

1
Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients.胃癌组织中 PD-1 阳性巨噬细胞的增加与胃癌患者的不良预后密切相关。
BMC Cancer. 2020 Mar 4;20(1):175. doi: 10.1186/s12885-020-6629-6.
2
SEOM clinical guideline for secondary prevention (2019).SEOM 临床指南:二级预防(2019 年)。
Clin Transl Oncol. 2020 Feb;22(2):187-192. doi: 10.1007/s12094-020-02302-0. Epub 2020 Jan 31.
3
Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.
整合转录组和代谢组学分析揭示雄激素非依赖性前列腺癌细胞中精氨酸代谢增强。
BMC Cancer. 2023 Dec 16;23(1):1241. doi: 10.1186/s12885-023-11707-3.
4
Multidimensional analysis to elucidate the possible mechanism of bone metastasis in breast cancer.多维分析阐明乳腺癌骨转移的可能机制。
BMC Cancer. 2023 Dec 8;23(1):1213. doi: 10.1186/s12885-023-11588-6.
5
Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer.综合分析和实验验证表明,CLCN4 升高是子宫内膜癌有前途的生物标志物。
Aging (Albany NY). 2023 Sep 5;15(17):8744-8769. doi: 10.18632/aging.204994.
6
Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma.泛癌症分析致癌基因 BARX2,鉴定其在肝肝细胞癌中的预后价值和免疫功能。
Sci Rep. 2023 May 9;13(1):7560. doi: 10.1038/s41598-023-34519-8.
7
A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification.基于 N7-甲基鸟苷修饰的肝细胞癌新预测模型。
BMC Gastroenterol. 2023 Apr 20;23(1):131. doi: 10.1186/s12876-023-02757-9.
8
KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.KIF2C 是一种与乳腺癌免疫细胞浸润相关的预后生物标志物。
BMC Cancer. 2023 Apr 4;23(1):307. doi: 10.1186/s12885-023-10788-4.
9
Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs).鉴定与癌症相关成纤维细胞(CAFs)相关的前列腺癌新治疗靶点和生物标志物。
Front Oncol. 2023 Mar 3;13:1136835. doi: 10.3389/fonc.2023.1136835. eCollection 2023.
10
Constructing a novel mitochondrial-related gene signature for evaluating the tumor immune microenvironment and predicting survival in stomach adenocarcinoma.构建一种新型的与线粒体相关的基因特征,用于评估胃腺癌的肿瘤免疫微环境并预测生存。
J Transl Med. 2023 Mar 13;21(1):191. doi: 10.1186/s12967-023-04033-6.
对 10 名埃及干燥综合征-莱尔综合征患者进行基因评估:扩展临床谱并报告一种新型 ALDH3A2 突变。
Arch Dermatol Res. 2019 Nov;311(9):721-730. doi: 10.1007/s00403-019-01953-6. Epub 2019 Aug 6.
4
Burden of Gastric Cancer.胃癌负担。
Clin Gastroenterol Hepatol. 2020 Mar;18(3):534-542. doi: 10.1016/j.cgh.2019.07.045. Epub 2019 Jul 27.
5
Immune checkpoint inhibitors: recent progress and potential biomarkers.免疫检查点抑制剂:最新进展与潜在生物标志物。
Exp Mol Med. 2018 Dec 13;50(12):1-11. doi: 10.1038/s12276-018-0191-1.
6
Increased Risk for Malignancies in 131 Affected Mutation Carriers.131 突变携带者恶性肿瘤风险增加。
Front Immunol. 2018 Sep 10;9:2012. doi: 10.3389/fimmu.2018.02012. eCollection 2018.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
Metabolomic alterations and chromosomal instability status in gastric cancer.胃癌中的代谢组学改变和染色体不稳定性状态。
World J Gastroenterol. 2018 Sep 7;24(33):3760-3769. doi: 10.3748/wjg.v24.i33.3760.
9
Progress in gastric cancer.胃癌的进展
Updates Surg. 2018 Jun;70(2):157-159. doi: 10.1007/s13304-018-0543-3. Epub 2018 Jun 5.
10
Profiling Tumor Infiltrating Immune Cells with CIBERSORT.使用CIBERSORT分析肿瘤浸润免疫细胞
Methods Mol Biol. 2018;1711:243-259. doi: 10.1007/978-1-4939-7493-1_12.